Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12920701 | 0.78 | APP (0.37) | APP | |
| SCHEMBL4053666 | 0.75 | APP (0.41) | APP | |
| SCHEMBL438937 | 0.74 | ADRB2 (0.36) | — | |
| SCHEMBL26986860 | 0.74 | ADRB2 (0.36) | — | |
| SCHEMBL458260 | 0.73 | — | — | |
| SCHEMBL8417586 | 0.72 | APP (0.38) | APP | |
| SCHEMBL3177040 | 0.72 | — | — | |
| SCHEMBL6763549 | 0.72 | APP (0.34) | APP | |
| SCHEMBL15384178 | 0.71 | DNM1 (0.47) | — | |
| SCHEMBL4926243 | 0.71 | DNM1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8772438-B2 | Preparation of polyamides | Invista North America S.är.l. (US) | 2014-07-08 | — | — | US | claimed |
| US-20120264907-A1 | PREPARATION OF POLYAMIDES | INVISTA NORTH AMERICA S.A.R.L. (US) | 2012-10-18 | — | — | US | claimed |
| EP-2451863-A1 | PREPARATION OF POLYAMIDES | Invista Technologies S.A R.L. (CH) | 2012-05-16 | — | — | EP | claimed |
| WO-2011004138-A1 | PREPARATION OF POLYAMIDES | INVISTA TECHNOLOGIES S.A.R.L. (CH) | 2011-01-13 | — | — | WO | claimed |
| EP-2640686-B1 | NITROUS OXIDE-CONTAINING IONIC LIQUIDS AS CHEMICAL REAGENTS | INVISTA TECH SARL (CH) | 2014-12-24 | — | — | EP | disclosed |
| US-8772438-B2 | Preparation of polyamides | Invista North America S.är.l. (US) | 2014-07-08 | — | — | US | disclosed |
| US-20130299738-A1 | NITROUS OXIDE-CONTAINING IONIC LIQUIDS AS CHEMICAL REAGENTS | INVISTA NORTH AMERICA S.A.R.L. (US) | 2013-11-14 | — | — | US | disclosed |
| EP-2640686-A2 | NITROUS OXIDE-CONTAINING IONIC LIQUIDS AS CHEMICAL REAGENTS | Invista Technologies S.A R.L. (CH) | 2013-09-25 | — | — | EP | disclosed |
| EP-2456807-B1 | SYNTHESIS METHOD USING IONIC LIQUIDS | INVISTA TECH SARL (CH) | 2013-07-17 | — | — | EP | disclosed |
| US-20120264907-A1 | PREPARATION OF POLYAMIDES | INVISTA NORTH AMERICA S.A.R.L. (US) | 2012-10-18 | — | — | US | disclosed |
| EP-2456807-A2 | SYNTHESIS METHOD USING IONIC LIQUIDS | Invista Technologies S.A R.L. (CH) | 2012-05-30 | — | — | EP | disclosed |
| WO-2012066296-A2 | NITROUS OXIDE-CONTAINING IONIC LIQUIDS AS CHEMICAL REAGENTS | INVISTA TECHNOLOGIES S.A.R. L. (CH) | 2012-05-24 | — | — | WO | disclosed |
| EP-2451863-A1 | PREPARATION OF POLYAMIDES | Invista Technologies S.A R.L. (CH) | 2012-05-16 | — | — | EP | disclosed |
| WO-2011010116-A2 | SYNTHESIS METHOD USING IONIC LIQUIDS | INVISTA TECHNOLOGIES S.À.R.L. (CH) | 2011-01-27 | — | — | WO | disclosed |
| WO-2011004138-A1 | PREPARATION OF POLYAMIDES | INVISTA TECHNOLOGIES S.A.R.L. (CH) | 2011-01-13 | — | — | WO | disclosed |
| EP-2051788-A1 | EXTRACTION PROCESS USING AN IONIC LIQUID | Invista Technologies S.à.r.l. (CH) | 2009-04-29 | — | — | EP | disclosed |
| US-7442841-B2 | Extraction process | INVISTA NORTH AMERICA S.A R.L. (US) | 2008-10-28 | — | — | US | disclosed |
| US-20080051609-A1 | EXTRACTION PROCESS | INVISTA NORTH AMERICA S.A.R.L. (US) | 2008-02-28 | — | — | US | disclosed |
| WO-2008022233-A1 | EXTRACTION PROCESS USING AN IONIC LIQUID | INVISTA TECHNOLOGIES S.A.R.L. (CH) | 2008-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051609-A1 | EXTRACTION PROCESS | ADH1C, ADH1A, ADH5 | APP 1637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.